HemaSphere
(Jun 2022)
P1204: TREATMENT PATTERNS AND REAL-WORLD OUTCOMES IN PATIENTS (PT) WITH LARGE B-CELL LYMPHOMA (LBCL) WHO RECEIVED SECOND-LINE (2L) THERAPY
- M. Lunning,
- M. Che,
- T. Gu,
- T. K. Le,
- F. F. Liu
Affiliations
- M. Lunning
- 1 University of Nebraska Medical Center, Omaha
- M. Che
- 2 Bristol Meyers Squibb, Princeton, United States of America
- T. Gu
- 2 Bristol Meyers Squibb, Princeton, United States of America
- T. K. Le
- 2 Bristol Meyers Squibb, Princeton, United States of America
- F. F. Liu
- 2 Bristol Meyers Squibb, Princeton, United States of America
- DOI
-
https://doi.org/10.1097/01.HS9.0000847680.18950.05
- Journal volume & issue
-
Vol. 6
pp.
1090
– 1091
WeChat QR code